Ophthalmology Times: October 2023

Physician notes endothelial cells play key role in hydration, transparency of cornea.

By taking a proactive approach to treatment, ophthalmologists can identify the “silent sufferers.”

New drugs are now in the pipeline to focus on treatment of the disease.

When patients pay for elective procedures, premium experience often falters.

Peter J. McDonnell's, MD, Chief medical editor of Ophthalmology times, editorial from the October 2023 issue.

BRIO-1 clinical trial sowing optimism as a potential therapeutic option.

Technology allows partitioning of sequencing reads into 2 parental genome data sets.

A new, larger 0.6-mm temporary plug is designed with a tapered edge.

Collaboration between ophthalmologists, optometrists can boost early detection.

Developing technology may offer marked improvements in surgical precision

Ocular graft-vs-host disease is not the garden variety dry eye.

Academy’s 2023 program taking place in San Francisco.

Physicians explore how other specialties adopted and integrated remote monitoring into plans.

Preservative-free Iyuzeh, launched more than 10 years ago, currently is available in 46 countries, mostly under the brand name Monoprost, with about 1.5 million patients treated monthly, according to the company.